United States · Series A startup

Who invested in Rondo Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$67Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $67MMar 2022
Investors
3
See who backed them

The rounds

  1. Mar 2022
    Series A$67M

    Source recorded

Founders and team

From Rondo Therapeutics's own website: 1 on the team.

  • Lynnae JacksonVP of Clinical Operations

AdvisersSteven James

Everyone who backed them

CanaanVC firm1round
Novo HoldingsVC firm1round
SV Health InvestorsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rondo Therapeutics

Who invested in Rondo Therapeutics?

Rondo Therapeutics's investors include Canaan, Novo Holdings and SV Health Investors.

How much has Rondo Therapeutics raised?

Rondo Therapeutics has raised $67M across 1 round since 2022.

When did Rondo Therapeutics last raise?

Rondo Therapeutics's most recent round was a Series A of $67M in Mar 2022.

What was Rondo Therapeutics's biggest round?

Its most recent round, $67M in Mar 2022, is also its largest on record.

Who backed Rondo Therapeutics first?

Rondo Therapeutics's first round on record, in Mar 2022, was backed by Canaan, Novo Holdings and SV Health Investors.

What stage is Rondo Therapeutics at?

Rondo Therapeutics's latest named round is a Series A, in Mar 2022.

Where is Rondo Therapeutics based?

Rondo Therapeutics is based in the United States.

Companies like Rondo Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.